NDC Package 70709-121-30 Venxxiva

Tiopronin Tablet, Delayed Release Oral - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
70709-121-30
Package Description:
300 TABLET, DELAYED RELEASE in 1 BOTTLE
Product Code:
Proprietary Name:
Venxxiva
Non-Proprietary Name:
Tiopronin
Substance Name:
Tiopronin
Usage Information:
This medication is used to prevent kidney stones in people with a certain inherited disorder (cystinuria). Cystinuria occurs when there is too much of a certain natural substance (the amino acid cystine) in the urine, leading to formation of kidney stones. Tiopronin works by making cystine more dissolvable in the urine. This medication should be used in combination with other methods to prevent kidney stones (such as drinking plenty of water, taking alkali treatment, following a special diet).
11-Digit NDC Billing Format:
70709012130
Billing Unit:
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
NDC to RxNorm Crosswalk:
300 EA
NDC to RxNorm Crosswalk:
Product Type:
Human Prescription Drug
Labeler Name:
Cycle Pharmaceuticals Ltd.
Dosage Form:
Tablet, Delayed Release - A solid dosage form which releases a drug (or drugs) at a time other than promptly after administration. Enteric-coated articles are delayed release dosage forms.
Administration Route(s):
Oral - Administration to or by way of the mouth.
Active Ingredient(s):
Sample Package:
No
FDA Application Number:
ANDA216990
Marketing Category:
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date:
01-22-2025
Listing Expiration Date:
12-31-2026
Exclude Flag:
N
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 70709-121-30?

The NDC Packaged Code 70709-121-30 is assigned to a package of 300 tablet, delayed release in 1 bottle of Venxxiva, a human prescription drug labeled by Cycle Pharmaceuticals Ltd.. The product's dosage form is tablet, delayed release and is administered via oral form.This product is billed for "EA" each discreet unit and contains an estimated amount of 300 billable units per package.

Is NDC 70709-121 included in the NDC Directory?

Yes, Venxxiva with product code 70709-121 is active and included in the NDC Directory. The product was first marketed by Cycle Pharmaceuticals Ltd. on January 22, 2025 and its listing in the NDC Directory is set to expire on December 31, 2026 if the product is not updated or renewed by the manufacturer.

What is the NDC billing unit for package 70709-121-30?

The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 300.

What is the 11-digit format for NDC 70709-121-30?

The 11-digit format is 70709012130. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
5-3-270709-121-305-4-270709-0121-30